FDA Investigator David M Beltran

David M Beltran has conducted inspections on 132 sites in 16 countries as of 07 Nov 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
07 Nov 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Netherlands, United States of America, France, Germany, Poland, Mexico, Sweden, Canada, Italy, Hungary, Australia, Curaçao, Denmark, United Kingdom of Great Britain and Northern Ireland, Spain, Switzerland
FDA Investigators that have inspected at least one site in common with David M Beltran:
Adaris Mas Rivera, Ademola O Daramola, Adrian Rodriguez, Akbar J Zaidi, Alan L Truong, Alan P Kurtzberg, Albert F Peacock, PhD, Alcee M Tavarez, Alicia M Mozzachio, Ana P Pineda Zavaleta, Andrea A Branche, Andrew J Barrowcliff, Andrew J Lang, Angela E Glenn, Angela K Shen, Anh M Lac, Anissa M Vargas, Anita R Michael, Anjali Shukla, PhD, Ann Marie Montemurro, Ann Marie Schofield, Anna Lazar, Aqualia L Nelson, Araceli Rey, RN, Arie C Menachem, Azza Talaat, Barbara J Rincon, Barbara Janine Breithaupt, Blondell W Johnson, Bo Chi, PhD, Brian J Ryan, Brittny C Cargo, Brook Shea, Bruce H Mccullough, Burnell M Henry, Camerson E Moore, Carl A Huffman, III, Carla A Norris, Carla J Lundi, Carol L Rehkopf, Caryn M Mcnab, CDR Ileana Barreto Pettit, Chana Fuchs, Charles D Brown, Charles I Ann, Charles L Zhou, Charles M Edwards, Chen Sun, PhD, Cheryl A Clausen, Chiang Syin, PhD, Christine A Harman, PhD, Christopher D Leach, Christopher D Rush, Christopher N Tran, Christopher T Middendorf, Chunsheng Cai, PhD, Cody D Rickman, Connie L Hannon Rabel, Corey K Reno, Cynthia A Harris, MD, RN, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Dale A Nyberg, Daniel J Lahar, Danny D Horner, Darla J Christopher, Darren S Brown, David J Eide, David K Lau, Deatherage Kayla, Deborah M Trout, Denicia L Salinas, Denise M Digiulio, Destry M Sillivan, Deyaa Shaheen, Diane L Raccasi, Djamila Harouaka, Don H Bark, PhD, Donald H Barks, Dongping Dai, PhD, Donna Ltartaglino Besone, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edwin Melendez, Edwin Ramos, Eileen A Liu, Eliezar Ramos, Elisa M Fleming, Elizabeth D Connell, Ellen J Kleintop, Ellen J Tave, Elmina E Akwo, Emily J Orban, Ernest Serna, III, Felix Maldonado, Francisco J Mendoza, Frederick F Razzaghi, Gene D Arcy, George R Smith, Gerald B Seaborn, Jr, Grace I Cortesini, Gretchen M Laws, Gwyn G Dickinson, H Ljamilla Selby, Habacuc V Barrera, Hala L Selby, Hamet M Toure, PharmD MPH, Helen B Ricalde, Iris C Macinnes, Ivis L Negron, J Elkins, Jacqueline Mdiaz Albertini, James A Beaulieu, James A Liubicich, James L Dunnie, Jr, James P Mcreavey, James R Evans, Jamie M Bumpas, Janice M Hickok, Jd Young, Jeffrey D Meng, Jeffrey R Wooley, Jennifer L Bridgewater, Jennifer M Gogley, Jeremy W Rotton, Jessica Chery, Joanne M Schlossin, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John T Chapman, Johnson, Jose Acruz Gonzalez, José E Meléndez, Jose Martinez, Jr, Joseph E Duran, Joshua J Silvestri, Juanita P Versace, Julianne C Mccullough, Julie D Bringger, Justin A Boyd, Kalavati Suvarna, PhD, Karen C Daugherty, Karen L Kosar, Kari M Johansen, Karlton T Watson, Katherine E Jacobitz, Kathleen Chmura Shaffer, Kathleen R Jones, PhD, Kathryn E Ogger, Katlin N Stubbs, Kenitra D Hewitt, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kevin P Regan, Kevin T Nguyen, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Kristen D Evans, Kristy A Zielny, Kula N Jha, L Grant, Lance Sindo, CIH, CQA, RS, Larry K Austin, Latorie S Jones, Latrecia D Stubbs, Lauren E Skokan, Laurie B Frazier, LCDR Debra Emerson, LCDR Michael H Tollon, Leighton Kn Gai, Leonard H Lavi, Liatte Kreuger, PharmD, Linda Linh N Adams, Linda M Cheny, Linda R Kuchenthal, Linda Thai, Lisa L Flores, Lisa M Bellows, Lisa M Puttonen, Lisa R Jennings, Lisa R Whitt, Liza L Quiles, Lloyd D Payne, Lori M Graham, Lorie S Hannappel, Lourdes R Genera, Lucas B Leake, Luis Mburgos Medero, Lynda L Perry, PhD, Lynnette I Riggio, Maira P Brading, Maotang Zhou, PhD, Marc R Dickens, Marcellinus D Dordunoo, Marcia G Evans, Margaret L Bolte, Margaret M Annes, Maria Estrella, Maria Joselopez Barragan, PhD, Marie B Buen Bigornia, Mark C Flotte, Marlene G Swider, Martha S Baldwin, Martrice A Packer, Marvin D Jones, Massoud Motamed, Matthew B Casale, Matthew J Sienko, Matthew R Maddox, Maya M Davis, Mei Chiung Huang (Jo), Meisha R Sampson, Meisha Waters, Melanie W Pishnery, Melissa J Garcia, Michael A Charles, Michael E Maselli, Michael R Goga, Michael S Smoker, Michael Shanks, MS, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Michelle A Krayer, Mihaly S Ligmond, Milva E Melendez Perales, Monica E Murie, Monique Rac Lester, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Nadeem I Chaudhry, Nancy T Waites, Natalya M Ananyeva, Navista C Bolton, Nerizza B Guerin, Nicholas A Violand, Nimmy Mathews, Oluwasefunm Agbanigo, Omotunde O Osunsanmi, Paraluman S Leonin, Parul M Patel, Patrice S Hall, Patricia D Stahnke, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patrick D Stone, MS, Patrick J Lynch, Patty P Kaewussdangkul, Paul A Bonneau, Paul E Frazier, Paul Mouris, Paula A Trost, Pauline N Logan, Philip M Steele, PhD, Phillip D Waldron, Prabhu P Raju, Rachel C Harrington, Rafael E Arroyo, Rafael Nevarez Nieves, Ralph A Erickson, Ralph H Vocque, Randa Melhem, PhD, Randy L Self, Raymond T Oji, Reba A Gates, Rebecca Co Bryan, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Reginald D Neal, Rendall E Barfoot, Reyes Candau Chacon, PhD, Rhonda L Dash, Rian L Pope, Richard K Vogel, Richard L Friedman, Richard Ledwidge (nmi), PhD, Richard W Thornton, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Rochelle K Kimmel, Rodney L Tinzie, Ronda Rloyd Jones, Rose Ashley, Roy Baby, Russell J Glapion, Russell K Riley, Saijal P Naik, Sakineh Walther, Saleem A Akhtar, Sandy J Ziegler, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Satheesh Thomas, Scott T Ballard, Sean M Cheney, Seneca D Toms, Sergey S Akimov, Seri L Essary, Sha'tina R Alridge, Shafiq S Ahadi, Shanna N Purdy, Sharon K Thoma, PharmD, Shawn E Larson, Shawn R Gould, Shelby N Turner, Sherrie L Krolczyk, Sidney B Priesmeyer, Simone E Pitts, Sina Shojaee, Staci G Mcallister, Stacie A Woods, Stephanie D Crockett, Stephen D Brown, Stephen L Beekman, Steven A Gonzales, Steven C Madzo, Steven P Donald, Susan M Jackson, Susan T Hadman, Susanna E Ford, Suzanne N Vallez, Tamera H Hunt, Tamil Arasu, PhD, Ted L Anderson, Temar Q Williams, Theresa Kirkham (NMI), Thomas A Peter, Thomas E Friel, Thomas J Arista, Tiara Nbrown Crosen, Tiffani D Wilson, Timothy H Vo, Toby Vern H Hill, Torrance J Slayton, Tracy J Washington, Travis M Beard, Travis S Bradley, Tricia S Martinez, Trina K Vick, Unnee Ranjan, Ve Garcia, Veronica L Call, Vivian Garcia, Vlada Matusovsky, Wayne E Seifert, Wendy G Tan, PhD, William J Leonard, Xiaokuang Lai, PhD, Xiuju Lu, Yiping Jia, Yvette S Montes, Zachary L Miller, Zhong Li, PhD

David M Beltran's Documents

Publish Date Document Type Title
October, 2002 FDA 483 Sovereign Pharmaceuticals, LLC - Form 483, 2002-10-24
May, 2008 FDA 483 Sovereign Pharmaceuticals, LLC - Form 483, 2008-05-12
April, 2000 FDA 483 Response Patheon Inc. - Form 483R, 2000-08-29
December, 2001 EIR Sterigenics U.S., LLC - EIR, 2001-12-13
February, 2003 EIR Alcon Research, LLC - EIR, 2003-02-21
October, 2007 FDA 483 Chemolee Lab Corporation - Form 483, 2007-10-11
September, 2004 FDA 483 Coats Aloe International, Inc. - Form 483, 2004-09-22
January, 2004 FDA 483 Neos Therapeutics, LP - Form 483, 2004-01-14
January, 2002 EIR Instituto Grifols, S.A. - EIR, 2002-01-11
September, 2001 EIR Sovereign Pharmaceuticals, LLC - EIR, 2001-09-27
April, 2000 FDA 483 Global Pharm Inc. - Form 483, 2000-04-06
December, 2000 FDA 483 Response Xellia Pharmaceuticals ApS - Form 483R, 2001-01-10
March, 2001 FDA 483 COATS Aloe International, Inc. - Form 483, 2001-04-21
September, 2001 FDA 483 Sovereign Pharmaceuticals, Ltd. - Form 483, 2001-09-27
May, 2003 FDA 483 Response Allergan Sales, LLC - Form 483R, 2003-05-30
October, 2000 FDA 483 Alcon Research, LLC - Form 483, 2000-10-27
May, 2008 EIR Sovereign Pharmaceuticals, LLC - EIR, 2008-05-12
May, 2003 EIR Allergan Sales, LLC - EIR, 2003-05-14
December, 2001 FDA 483 Sterigenics U.S., LLC - Form 483, 2001-12-13
January, 2004 FDA 483 Response Neos Therapeutics, LP - Form 483R, 2004-02-05
September, 2003 EIR Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) - EIR, 2003-10-22
October, 2002 EIR Sovereign Pharmaceuticals, LLC - EIR, 2002-10-24
November, 2003 FDA 483 Carrington Laboratories, Inc - Form 483, 2003-11-19
May, 2002 FDA 483 Response Carrington Laboratories, Inc - Form 483R, 2002-05-29
January, 2002 FDA 483 Response Instituto Grifols, S.A. - Form 483R, 2002-02-11
August, 2000 FDA 483 The University of Oklahoma - Form 483, 2000-08-04
June, 2007 FDA 483 IV Solutions of Lubbock - Form 483, 2007-06-08
November, 2001 EIR Alcon Research, LLC - EIR, 2001-11-15
March, 2002 FDA 483 Fareva Pau - Form 483, 2002-03-15
January, 2005 EIR Allergan Sales, LLC - EIR, 2005-01-28
September, 2004 EIR Coats Aloe International, Inc. - EIR, 2004-09-22
December, 2000 FDA 483 Xellia Pharmaceuticals ApS - Form 483, 2000-12-06
May, 2001 FDA 483 Response Wasserburger Arzneimittelwerk GmbH - Form 483R, 2001-05-22
March, 2002 EIR Fareva Pau - EIR, 2003-11-19
October, 2000 FDA 483 Response Alcon Research, LLC - Form 483R, 2000-11-03
April, 2005 EIR Alcon Research, LLC - EIR, 2005-04-13
September, 2000 FDA 483 Warren Laboratories, LLC - Form 483, 2000-09-15
February, 2001 EIR Alcon Research, LLC - EIR, 2001-02-16
December, 2002 EIR Sanofi S.r.l. - EIR, 2002-12-13
May, 2000 FDA 483 DSM Biologics - Form 483, 2000-05-12
May, 2002 EIR Carrington Laboratories, Inc - EIR, 2002-05-10
December, 2000 EIR Xellia Pharmaceuticals ApS - EIR, 2000-12-06
January, 2005 FDA 483 Allergan Sales, LLC - Form 483, 2005-01-28
September, 2003 FDA 483 Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) - Form 483, 2003-09-22
March, 2006 FDA 483 OKC Allergy Supplies, Inc. - Form 483, 2006-03-09
January, 2005 FDA 483 Response Allergan Sales, LLC - Form 483R, 2005-02-18
August, 2002 FDA 483 Response ICU Medical INC. - Form 483R, 2002-09-11
August, 2002 FDA 483 ICU Medical INC. - Form 483, 2002-08-28
March, 2001 EIR Coats Aloe International, Inc. - EIR, 2001-03-21
May, 2002 FDA 483 Carrington Laboratories, Inc - Form 483, 2002-05-10
February, 2003 FDA 483 Alcon Research, LLC - Form 483, 2003-02-21
May, 2003 FDA 483 Allergan Sales, LLC - Form 483, 2003-05-14
October, 2000 EIR Alcon Research, LLC - EIR, 2000-10-27
August, 2002 EIR ICU Medical INC. - EIR, 2002-08-28
September, 2003 EIR Sanofi-Aventis Deutschland GmbH - EIR, 2003-11-07
March, 2001 FDA 483 Response Coats Aloe International, Inc. - Form 483R, 2001-04-16
September, 2000 EIR ICU Medical INC. - EIR, 2000-09-15
May, 2001 EIR Wasserburger Arzneimittelwerk GmbH - EIR, 2001-09-05
June, 2006 FDA 483 Carrington Laboratories, Inc - Form 483, 2006-06-23
April, 2005 FDA 483 Alcon Research, LLC - Form 483, 2005-04-13
January, 2002 FDA 483 Instituto Grifols, S.A. - Form 483, 2002-01-11
January, 2007 FDA 483 Sovereign Pharmaceuticals, LLC - Form 483, 2007-01-05
April, 2000 EIR Patheon Inc. - EIR, 2000-08-23
November, 2007 FDA 483 United Laboratories Manufacturing, LLC - Form 483, 2007-11-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more